Literature DB >> 17323334

Major pancreatic resections for suspected cancer in a community-based teaching hospital: lessons learned.

Ramaz E Metreveli1, Katherine Sahm, Raafat Abdel-Misih, Nicholas J Petrelli.   

Abstract

BACKGROUND: The literature reports 4-10% mortality rate, 30-60% morbidity rate, and 9-29% anastomotic leak rate after pancreaticoduodenectomy (PD) performed for periampullary tumors. These data demonstrate a linear relationship between surgical volume and outcome.
METHODS: The objective of this study was to evaluate the experience of a high-volume hospital with low-volume pancreatoduodenectomy for suspected cancer. The study was designed as a retrospective review of medical records of all patients who underwent pancreatoduodenal resection or total pancreatectomy for a suspected periampullary carcinoma between January 1994 and December 2003. The setting of the study was a community-based teaching hospital with a general surgery residency training program.
RESULTS: A total of 63 patients underwent pancreatoduodenal resection or total pancreatectomy. All procedures were performed by a total of 15 different surgeons; however, 27 operations were performed by one surgeon. Pre-operative diagnosis in most cases was either a known malignancy-27 cases (43%) or a tumor of the head of the pancreas, suspicious for malignancy-36 cases (57%). One patient underwent a total pancreatectomy. In 62 patients a pancreatoduodenal resection (Whipple procedure) was performed. Post-operative 30-day mortality was 4.7% (three patients). Overall in-hospital mortality was 9.5% (six patients). Ten (16.1%) had a leak of the pancreato-jejunal anastomosis, six of which resolved with non-operative management. Of the remaining four patients, three died from peritonitis or consequences of erosive hemorrhage.
CONCLUSIONS: Post-operative leak of the pancreatic anastomosis represents a technical challenge. Although most of the leaks can be treated non-operatively, those that lead to peritonitis or erosive hemorrhage warrant operative intervention. Major pancreatic resections can be performed safely with low rates of morbidity and operative mortality with careful selection of patients at a low-volume community-based teaching hospital.

Entities:  

Mesh:

Year:  2007        PMID: 17323334     DOI: 10.1002/jso.20662

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  10 in total

1.  Frequency with which surgeons undertake pancreaticoduodenectomy continues to determine length of stay, hospital charges, and in-hospital mortality.

Authors:  Alexander Rosemurgy; Sarah Cowgill; Brian Coe; Ashley Thomas; Sam Al-Saadi; Steven Goldin; Emmanuel Zervos
Journal:  J Gastrointest Surg       Date:  2007-12-22       Impact factor: 3.452

2.  Pancreaticoduodenal resection for malignancy in a low-volume center: long-term outcomes from a developing country.

Authors:  Abu Bakar Hafeez Bhatti; Mohammad Aasim Yusuf; Syed Ather Saeed Kazmi; Aamir Ali Syed
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

3.  Surgeon volume versus morbidity and cost in patients undergoing pancreaticoduodenectomy in an academic community medical center.

Authors:  Timothy J Kennedy; Maria A Cassera; Ronald Wolf; Lee L Swanstrom; Paul D Hansen
Journal:  J Gastrointest Surg       Date:  2010-07-30       Impact factor: 3.452

4.  Starting a High-Quality Pancreatic Surgery Program at a Community Hospital.

Authors:  Jeffrey M Hardacre; Siavash Raigani; John Dumot
Journal:  J Gastrointest Surg       Date:  2015-09-10       Impact factor: 3.452

5.  Management of periampullary adenocarcinoma by pancreaticoduodenectomy at a regional teaching hospital.

Authors:  Brian McKinley; Simon Lehtinen; Scott Davis; Justin Collins; Dawn Blackhurst; Christine Marie-Gilligan Schammel; David P Schammel; Steven D Trocha
Journal:  J Gastrointest Oncol       Date:  2015-08

6.  Outcomes following pancreatic resection: variability among high-volume providers.

Authors:  Taylor S Riall; William H Nealon; James S Goodwin; Courtney M Townsend; Jean L Freeman
Journal:  Surgery       Date:  2008-08       Impact factor: 3.982

7.  Impact of cardiac comorbidity on early outcomes after pancreatic resection.

Authors:  Sean M Ronnekleiv-Kelly; David Y Greenblatt; Chee Paul Lin; Kaitlyn J Kelly; Clifford S Cho; Emily R Winslow; Sharon M Weber
Journal:  J Gastrointest Surg       Date:  2013-11-26       Impact factor: 3.452

8.  Treatment of pancreatic and periampullary cancers at a community hospital: successful application of tertiary care treatment standards.

Authors:  Robert C Moesinger; Jan W Davis; Britani Hill; W Cory Johnston; Carl Gray; Harold Johnson; Leslye Ingersoll; Gary Whipple; Mark Reilly; Robert Harris; Vincent Hansen
Journal:  Int J Surg Oncol       Date:  2011-12-19

9.  Protective Ventilation Improves Gas Exchange, Reduces Incidence of Atelectases, and Affects Metabolic Response in Major Pancreatoduodenal Surgery.

Authors:  Vsevolod V Kuzkov; Ludmila N Rodionova; Yana Y Ilyina; Aleksey A Ushakov; Maria M Sokolova; Eugenia V Fot; Boris L Duberman; Mikhail Y Kirov
Journal:  Front Med (Lausanne)       Date:  2016-12-06

10.  Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma.

Authors:  Hiroyuki Kashiwagi; Jonathan E McDunn; Peter O Simon; Peter S Goedegebuure; Suwanna Vangveravong; Katherine Chang; Richard S Hotchkiss; Robert H Mach; William G Hawkins
Journal:  J Transl Med       Date:  2009-03-26       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.